YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...

MediWound, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III trial for its treatment for venous leg ulcers. The ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure ...

A new device for meibomian gland debridement was safe and effective and demonstrated time and space benefits compared with conventional debridement and expression approaches, according to a study ...

Discover a review in which diabetes was investigated in 5 studies, with only one demonstrating a correlation between the condition and higher hospital readmission rates.

A teenager was stabbed to death in Maharashtra’s Wardha district after an argument over an Instagram post. Police have ...

The OKC Thunder found a way to thrive via committee during the absence of Chet Holmgren, who returned in a win over Toronto ...

The Chicago Bulls and point guard Lonzo Ball have agreed to a two-year contract extension, according to ESPN’s Shams Charania ...

NAGAPATTINAM: A 37-year-old woman lost her pair of legs to a freak accident at a private flour mill near Nagapattinam on ...